Xopenex HFA (levalbuterol) is a prescription drug that helps prevent and treat breathing difficulties from sudden airway tightness. The drug comes as an aerosol inhaler. It’s usually used every 4 to 6 ...

COPD - Chronic Obstructive Pulmonary Disease - including chronic bronchitis and emphysema, is characterized by breathing difficulty due to partial blockage of the bronchial tubes. Asthma is a chronic ...

Xopenex HFA (levalbuterol) has potential interactions with other medications and some supplements. These interactions could affect how well the drug works or cause harmful effects. An interaction can ...

Levalbuterol (as tartrate) (single-isomer albuterol) 45mcg/inh; metered dose inhaler; CFC-free. Do not exceed recommended dose. Monitor for increased need; if inadequate control, reevaluate and ...

DUBLIN--(BUSINESS WIRE)--The "Xopenex - Drug Insight, 2019" report has been added to ResearchAndMarkets.com's offering. Xopenex Drug Insight, 2019 highlights the drug marketed details and the Global ...

Development of levalbuterol was based on the following proposed advantages over racemic albuterol [3]: fewer episodes of transient tachycardia, better tolerability, and similar or greater efficacy. An ...

Watson Pharmaceuticals has launched an authorized generic version of Xopenex (levalbuterol HCl) Inhalation Solution. This is part of an agreement Watson has with Sunovion Pharmaceuticals, who ...

NEW YORK, March 10 (Reuters) - Sepracor Inc said on Tuesday it had reached a settlement that will allow Israeli drugmaker Teva Pharmaceutical Industries Ltd to begin selling a generic form of Sepracor ...

March 17, 2005 — The U.S. Food and Drug Administration (FDA) has approved a new indication for temozolomide, allowing its use in the first-line treatment of glioblastoma multiforme; orphan drug status ...

Marlborough-based Sunovion Pharmaceuticals said it has agreed to sell rights to its drug Xopenex Inhalation Solution (IS), used in the treatment of obstructive airway disease such as asthma. Niche ...

Sunovion Pharmaceuticals Inc. to Divest Xopenex® (levalbuterol HCI) Inhalation Solution (IS) to Akorn, Inc. MARLBOROUGH, Mass., Sep 30, 2014 (BUSINESS WIRE) -- Sunovion Pharmaceuticals Inc. (Sunovion) ...

Levalbuterol (as tartrate) (single-isomer albuterol) 45mcg/inh; metered dose inhaler; CFC-free. The pharmacological effects of beta 2-adrenoceptor agonist drugs are at least in part attributable to ...